The only pediatric Lymphoma Program in the country that is dedicated to focusing solely on childhood lymphoma and lymphoproliferative disorders. The country's best pediatric cell and gene therapy and new drug development programs participate in the program.
The Texas Children's Cancer Center Lymphoma Program is a multidisciplinary clinical, laboratory research, clinical research and education program that provides state-of-the-art, comprehensive care to children with pediatric lymphomas and lymphoproliferative disorders.
The Lymphoma Program is comprehensive, researching new means of diagnosing, monitoring, predicting behavior of, as well as treating and preventing disease. It is multidisciplinary, utilizing experts from pediatric oncology, surgery, pharmacology, stem cell transplant, molecular oncology, gene therapy and cell therapy.
Our team treats children with Hodgkin’s Lymphoma (Hodgkin’s Disease), Burkitt’s Lymphoma, B cell lymphoma, T cell lymphoma, anaplastic large cell lymphoma, post-transplant lymphoproliferative disorder, lymphadenopathy (enlarged lymph nodes), auto-immune lymphoproliferative disease (ALPS), AIDs-related lymphoma, and other white blood cell disorders.
At Texas Children’s Hospital, we also care for patients with Histiocytic Disorders.
The Texas Children's Cancer Center Histiocytosis Program is the largest Histiocytosis Clinic in the world. At Texas Children's Hospital, histiocytic disorders are not rare. Histiocytic disorders include Langerhans Cell Histiocytosis, Hemophagocytic Lymphohistiocytosis.